$Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas$

Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2020-03, Vol.135 (11), p.862-865
Hauptverfasser:	Srour, S.A., Singh, H., McCarty, J., de Groot, E., Huls, H., Rondon, G., Qazilbash, M., Ciurea, S., Bardelli, G., Buck, J., Alousi, A., Nieto, Y., Rezvani, K., Marin, D., Popat, U., Hosing, C., Shpall, E.J., Wierda, W.G., Kantarjian, H., Champlin, R.E., Cooper, L.J., Kebriaei, P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antigens, CD19 - immunology Antigens, CD19 - metabolism Antigens, Neoplasm - immunology Humans Immunotherapy, Adoptive Letter to Lymphoma, B-Cell - immunology Lymphoma, B-Cell - therapy Male Middle Aged Receptors, Antigen, T-Cell - genetics Receptors, Antigen, T-Cell - metabolism Receptors, Chimeric Antigen - genetics Receptors, Chimeric Antigen - metabolism T-Lymphocytes - immunology T-Lymphocytes - metabolism Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!